China Money Network
Login
Join

Chinese Biopharma Firm Apollomics Completes $120M Financing

  • November 10, 2020 — 04:05 CST

This Data Is Locked!

This area is available only to Subscribers.

Apollomics, Inc., an innovative biopharmaceutical company dedicated to the discovery and development of new tumor-targeting and immune drugs and their combination therapies, announced that it... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: